Send Inquiry

Request To Call Back

Apragem Gemcitabine Injection

Get a Price/Quote

MOQ : 1 Bottle

Apragem Gemcitabine Injection Specification

Origin of Medicine
Allopathic

Pacakaging (Quantity Per Box)
Each box contains 1 vial

Indication
Pancreatic, lung, ovarian and breast cancer

Salt Composition
Gemcitabine Hydrochloride

Dosage Form
Injection

Drug Type
Prescription

Ingredients
Gemcitabine

Physical Form
Liquid

Function
Anti-cancer / Antineoplastic

Recommended For
As directed by the physician

Dosage
38Mg/ml

Dosage Guidelines
Intravenous use only, dosage as prescribed by oncologist

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store below 25C, protected from light

Brand Name
Apragem

Pack Size
1 vial (1000 mg/26.3 ml)

ATC Code
L01BC05

Strength
38 mg/ml

Appearance
Clear colorless solution

Shelf Life
2 years from manufacture date

Prescription/Non Prescription
Prescription

Contraindications
Hypersensitivity to gemcitabine or any component

Marketed By
Aprazer Healthcare Pvt Ltd

Usage
For hospital and institutional use only

Route of Administration
IV (intravenous)

Apragem Gemcitabine Injection Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
pack of 1 vial.

Main Domestic Market
All India

About Apragem Gemcitabine Injection

Specification :-

Brand Name : Apragem

Content : Gemcitabine

Form : Injection

Strength : 38Mg/ml

Packing : Pack Of 1 vial

Manufactured By-: Aprazer

Note :- Apragem Is A Prescription Drug And Should Be Used Unde
Proper Medical Guidance And Advice. Do Not Share The Medicine
With Others, Since They May Be Suffering From A Problem That Is
Not Effectively Treated By This Drug.

Advanced Antineoplastic Therapy

Apragem Gemcitabine Injection provides a reliable solution for various aggressive cancers, including pancreatic, lung, breast, and ovarian malignancies. As an allopathic formulation, it is widely recommended by oncologists for its proven efficacy and tolerability in adult patients.

Precise Hospital-Use Formulation

Manufactured and marketed by Aprazer Healthcare Pvt Ltd, Apragem injection is only available for use in hospitals and healthcare institutions. Its controlled intravenous administration requires prescription and medical supervision to ensure optimal treatment outcomes and safety.

Storage and Handling Instructions

Apragem must be stored below 25C, away from direct light, to maintain its potency throughout its two-year shelf life. Healthcare professionals should handle and administer the product according to established oncology protocols to safeguard efficacy and patient safety.

FAQs of Apragem Gemcitabine Injection:

Q: How should Apragem Gemcitabine Injection be administered?

A: Apragem Gemcitabine Injection is administered intravenously under the supervision of an oncologist or healthcare professional. The dosage and schedule are determined by the physician based on the patients specific cancer type and condition.

Q: What types of cancer is Apragem indicated for?

A: This medication is indicated for the treatment of pancreatic, lung, ovarian, and breast cancers, as prescribed by a qualified oncologist.

Q: When should a patient avoid using Apragem Gemcitabine Injection?

A: Patients with known hypersensitivity to gemcitabine or any component of the injection should not use this medicine. Always consult a physician for suitability before initiating treatment.

Q: Where can Apragem Gemcitabine Injection be administered?

A: Apragem is intended exclusively for administration in hospitals or medical institutions, under medical supervision. It is not suitable for home use.

Q: What is the recommended storage condition for Apragem?

A: Store Apragem below 25C, protected from light, to maintain its integrity and efficacy throughout its shelf life. Always follow hospital protocols for handling chemotherapy medicines.

Q: What is the core benefit of using Apragem for cancer patients?

A: Apragem offers targeted anti-cancer activity and is recognized for its effectiveness against several common malignancies, allowing for tailored therapy under oncological guidance.

Tell us about your requirement